The Dana-Farber Cancer Institute this week filed a "institutional master plan" for its proposed 14-story hospital where the Joslin Diabetes Center now sits. The 10-year development plan does not have detailed renderings of the new hospital - to be built as part of a new long-term agreement with Beth Israel Medical Center - but it does call for construction of new pedestrian bridges, including one that would span Brookline Avenue from the new building to Dana-Farber's current facilities. Read more.
Dana-Farber
Rough sketch of the proposed new building.
Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center today filed an "institutional master plan" with details, if not architectural renderings, of their proposed 14-story cancer hospital on what is now the site of the Joslin Diabetes Center. Read more.
Beth Israel Deaconess Medical Center and the Dana-Farber Cancer Center wasted no time with their new partnership, yesterday telling the BPDA they will soon file detailed plans for razing the current Joslin Diabetes Center off Brookline Avenue to make way for a new, 14-story cancer hospital. Read more.
Boston Police report arresting Tyler Baker, 36, on charges he's the guy who ran up to a woman and punched her in the head for no reason outside the Dana-Farber Cancer Institute on Jimmy Fund Way on Oct. 5.
Baker was charged with aggravated assault and battery, police say.
Innocent, etc.
Update: Suspect charged.
Boston Police report they are looking for a man they say ran up to a woman standing outside the Dana-Farber Cancer Institute on Jimmy Fund Way and punched her in the right side of her head, around 10 a.m. on Monday. Read more.
The cancer center reports it now has less than a day's worth of O-negative blood and is looking for folks with that type who could make a donation.
The Dana-Farber Cancer Institute is suing a Japanese researcher it says patented a promising method for battling cancer that is based on work by researchers at Dana-Farber and Genetics Institute in Cambridge. A Japanese drug company and Bristol-Myers Squibb are also named. Read more.
The Dana-Farber Cancer Institute says rights to the novel chemical invented by Dr. Nathanael Gray actually belong to pharmaceutical giant Novartis, in a lawsuit filed in U.S. District Court in Boston yesterday.
Novartis and Dana-Farber have a research-funding agreement in which Novartis gets first dibs on any potential anti-cancer agents developed by Dana-Farber researchers who have agreed to take Novartis money.
Kate Jackson recounts a day of chemotherapy at Dana-Farber on a holiday:
For round 2 of the red death, we scored a window seat away from the main row; a safe haven from front desk gawkers and wandering, spaced-out chaplains. Instead of viewing patients filling out forms, we look upon blue skies and the interconnecting rooftops of JP and Brookline. It's like a Lisa Daria painting.
James and I are setting up shop with our laptops, books, mags and other articles of distraction when our chemo "neighbors" show up. They are an older couple who move in ways that suggest they've been doing this for a while. They immediately -- and mercifully -- draw the curtain. "Not that we don't like you guys," the gentlemen says from his side. "That's fine," we say from ours.
We're just glad someone took the initiative. We're still unsure of the protocol on who draws the curtain first. ...
Ironworkers building Yawkey Cancer Center structure find way to cheer up cheer up Dana-Farber child patients.
Globe story by Michael Levenson, with video by photog John Tlumacki.
![Subscribe to Dana-Farber](https://www.universalhub.com/misc/feed.png)